Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 7,310 shares at $32.12 ($235K) on 2026-02-03, disclosed to the SEC on 2026-02-03.
Seasonal sale ($235k) by CHIEF COMMERCIAL OFFICER — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |
| TVTX | SELL | 2025-11-04 | $196K | — | Filing → |